Synthesis of (R) and (S) enantiomers of Fmoc-protected 1,2,4-oxadiazole-containing β3-amino acids from Fmoc-(R)-β-HAsp(OtBu)-OH

Tetrahedron Letters

Volumn 44, Issue 32, 2003, Pages 6079-6082

  Hamzé, Abdallah ^a   Hernandez, Jean François ^a   Martinez, Jean ^a  

^a CNRS   (France)

Author keywords

1,2,4 oxadiazole; Fmoc; 3 amino acid

Indexed keywords

1,2,4 OXADIAZOLE DERIVATIVE; ACETIC ACID; AMINO ACID DERIVATIVE;

ARTICLE; CATALYST; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER;

EID: 0037629639     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(03)01471-0     Document Type: Article

References (39)

1. Crews P., Manes L.V., Boelher M. Tetrahedron Lett. 27:1986;2797-2800.
2. De Rosa S., De Guilio A., Tommonaro G., Popov S., Kujumgiev A. J. Nat. Prod. 63:2000;1454-1455.
3. Ojima I., Lin S., Wang T. Curr. Med. Chem. 6:1999;927-954.
4. Nicolaou K.C., Dai W.M., Guy R.K. Angew. Chem., Int. Ed. Engl. 33:1994;15-44.
5. Seebach D., Overhand M., Kühle F.N.M., Martinoni B. Helv. Chim. Acta. 79:1996;913-941.
6. Gademann K., Jaun B., Seebach D. Helv. Chim. Acta. 82:1999;1-11.
7. Gellman S.H. Acc. Chem. Res. 31:1998;173-180.
8. DeGrado W.F., Schneider J.P., Hamuro Y. J. Peptide Res. 54:1999;206-217.
9. Cheng R.P., Gellman S.H., DeGrado W.F. Chem. Rev. 101:2001;3219-3232.
10. Seebach D., Abele S., Schreiber J.V., Martinoni B., Nussbaum A.K., Schild H., Schulz H., Henneke H., Woessner R., Bitsch F. Chimia. 52:1998;734-739.
11. Frackenpohl J., Arvidsson P.I., Schreiber J.V., Seebach D. Chembiochem. 2:2001;445-455.
12. Cardillo G., Gentilucci L., Qasem A.R., Sgarzi F., Spampinato S. J. Med. Chem. 45:2002;2571-2578.
13. Sagan S., Milcent T., Ponsinet R., Convert O., Tasseau O., Chassaing G., Lavielle S., Lequin O. Eur. J. Biochem. 270:2003;939-949.
14. Huck, J. PhD Thesis, University of Montpellier II, France, 2002.
15. Behr L.C. Weissberger A. The Chemistry of Heterocyclic Compounds. 17:1962;245-262 John Wiley, New York.
16. Clapp L.B. Katritzky A.R. Advances in Heterocyclic Chemistry. 20:1976;65-116 Academic Press, New York.
17. Hemming K. J. Chem. Res., Synopses. 2001;209-216. and 601-620.
18. Diana G.D., Volkots D.L., Nitz J.T., Bailey R.T., Long M.A., Vescio N., Aldous S., Peveur D.C., Dutko F.J. J. Med. Chem. 37:1994;2421-2436.
19. Andersen K.E., Jorgensen A.S., Braestrup C. Eur. J. Med. Chem. 29:1994;393-399.
20. Andersen K.E., Lundt B.F., Joergensen A.S., Braestrup C. Eur. J. Med. Chem. 31:1996;417-425.
21. Naka T., Kubo K. Curr. Pharm. Des. 5:1999;453-472.
22. Liu M., Sibi M.P. Tetrahedron. 58:2002;7991-8035.
23. Müller A., Vogt C., Sewald N. Synthesis. 1998;837-841.
24. Ellmerer E.P., Brössner D., Maslouh N., Tako A. Helv. Chim. Acta. 81:1998;59-65.
25. Ananda K., Gopi H.N., Suresh Babu V.V. J. Peptide Res. 55:2000;289-294.
26. 4, tetrakis(triphenylphosphine)palladium(0); TBAF, tetra-n-butylammonium fluoride; TFA, trifluoroacetic acid.
27. Eloy F.R.L. Chem. Rev. 62:1962;155-183.
28. Weller, H. N.; Poss, M. A.; E. R. Squibb & Sons, Inc.; US 5,236,916, 17 Aug. 1993.
29. Deegan T.L., Nitz T.J., Cebzanov D., Pufko D.E., Porco J.A. Jr. Bioorg. Med. Chem. Lett. 9:1999;209-212.
30. Poulain R.F., Tartar A.L., Déprez B.P. Tetrahedron Lett. 42:2001;1495-1498.
31. Borg S., Estenne-Bouhtou G., Luthman K., Csöregh I., Hesselink W., Hacksell U. J. Org. Chem. 60:1995;3112-3120.
32. Buchanan J.L., Vu C.B., Merry T.J., Corpuz E.G., Pradeepan S.G., Mani U.N., Yang M., Plake H.R., Varkhedkar V.M., Lynch B.A., MacNeil I.A., Loiacono K.A., Tiong C.L., Holt D.A. Bioorg. Med. Chem. Lett. 9:1999;2359-2364.
33. Rice K., Nuss J.M. Bioorg. Med. Chem. Lett. 11:2001;753-755.
34. Gangloff A.R., Litvak J., Shelton E.J., Sperandio D., Wang V.R., Rice K.D. Tetrahedron Lett. 42:2001;1441-1443.
35. Hébert N., Hannah A.L., Sutton S.C. Tetrahedron Lett. 40:1999;8547-8550.
36. Hébert, N.; Hannah, A. L.; Trega Biosciences, WO 00/25768 A1, 11 May 2000.
37. 3), 1.38 (s, 9H, tBu).
38. 3).
39. 2β′).